US2153653A - Irradiated dusting powder - Google Patents
Irradiated dusting powder Download PDFInfo
- Publication number
- US2153653A US2153653A US58227A US5822736A US2153653A US 2153653 A US2153653 A US 2153653A US 58227 A US58227 A US 58227A US 5822736 A US5822736 A US 5822736A US 2153653 A US2153653 A US 2153653A
- Authority
- US
- United States
- Prior art keywords
- irradiated
- dusting powder
- gypsum
- powder
- anhydrite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000843 powder Substances 0.000 title description 8
- 238000010410 dusting Methods 0.000 title description 6
- 229910052602 gypsum Inorganic materials 0.000 description 10
- 239000010440 gypsum Substances 0.000 description 10
- 229910052925 anhydrite Inorganic materials 0.000 description 5
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 5
- 230000035876 healing Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Definitions
- This invention relates to irradiated dusting powder suitable more particularly for use in the to the action of chemically efi'ective light rays.
- the 15 powder is heated to about 100 C. preferably in a stirring or agitating devices. After having cooled down to about 60 0., the powder is then irradiated with-chemically potent rays, preferably by passing it under powerful quartz lamps in a thin layer spread out on conveyor belts.
- quartz lamps there can be employed any other lamps capable of'emitting ultra-violet rays.
- the dusting 25 powder produced in this manner which, as already mentioned, is suitable not only for the treatment of the healthy skin but also for healing eczema, there can also be added to the powdered gypsum other specifically eifective sub- I 30 stances both of an inorganic and of an organic nature. This addition can be given either bei'ore, during, or alter the irradiatim with ultraviolet rays..
- inorganic supplement there can be added for" example zinc oxide, which en- 35 hances the healing power, and as an organic,'pulverised camomile blossoms which likewise pro-- mote the healing of eczema and prevent irritatlon of the skin.
- anhydrite is to be understood as meaning both the natural mineral known as anhydrite and also artificial anhydrlte obtained by overburning gypsum. If a mixture of gypsum and anhydrlte be employed for the purpose of the present in- 10 vention an interaction is set up between the anhydrite and the hydrated gypsum, which does not 'exert the slightest irritation on the skin but which has a beneficial effect on herpes and discharging afi'ections and outbreaks. 'I'heefi'ect can be varied at will by altering the proportions of anhydrite and hydrated gypsum in the mixture.
- A medicating dust-comprisinga mixture of roasted gypsum and anhydrlteirradiated by ultra-violet rays.
Description
Patented Apr. 11,1939
UNITED STATES PATENT OFFICE IRRADIATED DUSTING POWDER Gustav Stux, Vienna, Austria No Drawing. Application January s, 1930, Serial No. 58,227. in Austria January 5, 1m
1 Claim.
This invention relates to irradiated dusting powder suitable more particularly for use in the to the action of chemically efi'ective light rays.
'Ihe yp um used may not be dead burned, and is pulverized extremely fine and purified before sterilization. For the purpose of sterilization the 15 powder is heated to about 100 C. preferably in a stirring or agitating devices. After having cooled down to about 60 0., the powder is then irradiated with-chemically potent rays, preferably by passing it under powerful quartz lamps in a thin layer spread out on conveyor belts. Instead of quartz lamps there can be employed any other lamps capable of'emitting ultra-violet rays.
In order to increase the efilcacy oi the dusting 25 powder produced in this manner, which, as already mentioned, is suitable not only for the treatment of the healthy skin but also for healing eczema, there can also be added to the powdered gypsum other specifically eifective sub- I 30 stances both of an inorganic and of an organic nature. This addition can be given either bei'ore, during, or alter the irradiatim with ultraviolet rays.. As an inorganic supplement there can be added for" example zinc oxide, which en- 35 hances the healing power, and as an organic,'pulverised camomile blossoms which likewise pro-- mote the healing of eczema and prevent irritatlon of the skin.
I have further found that skin irritation can be avoided entirely by using instead of gypsum amixture of gypsum and anhydrite. The term 5 anhydrite is to be understood as meaning both the natural mineral known as anhydrite and also artificial anhydrlte obtained by overburning gypsum. If a mixture of gypsum and anhydrlte be employed for the purpose of the present in- 10 vention an interaction is set up between the anhydrite and the hydrated gypsum, which does not 'exert the slightest irritation on the skin but which has a beneficial effect on herpes and discharging afi'ections and outbreaks. 'I'heefi'ect can be varied at will by altering the proportions of anhydrite and hydrated gypsum in the mixture.
It is known to use gypsum in the production of dusting powder (cl. Hager's "Handbuch der pharmazeutischen Praxis, Vol. I, 1925, page 766); the treatment of foodstuifs and remedial substances, such as fat, and lets and similar substances incorporated in ointments and creams containing or free from mineral additions, with 25 ultra-violet rays has likewise already been proposed (cf. Austrian Patents Nos. 118,782 and 121,657) It has been unknown as yet, however,
to treat dusting powder containing gypsum as the main constituent, with ultra-violet rays for 30 the purpose of enhancingits healing action I claim:
A: medicating dust-comprisinga mixture of roasted gypsum and anhydrlteirradiated by ultra-violet rays.
cus'rav s'rux
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT2153653X | 1932-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2153653A true US2153653A (en) | 1939-04-11 |
Family
ID=3689977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US58227A Expired - Lifetime US2153653A (en) | 1932-01-05 | 1936-01-08 | Irradiated dusting powder |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2153653A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2537530A (en) * | 1947-10-30 | 1951-01-09 | Hofman Emil | Means for treating materials to kill bacteria, bacilli, and unsavory odors therein |
| US5032408A (en) * | 1985-05-28 | 1991-07-16 | Chemisch Adviesburea Drs. J.C.P. Schruder | Composition for treatment of skin affections and process for its preparation |
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
-
1936
- 1936-01-08 US US58227A patent/US2153653A/en not_active Expired - Lifetime
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2537530A (en) * | 1947-10-30 | 1951-01-09 | Hofman Emil | Means for treating materials to kill bacteria, bacilli, and unsavory odors therein |
| US5032408A (en) * | 1985-05-28 | 1991-07-16 | Chemisch Adviesburea Drs. J.C.P. Schruder | Composition for treatment of skin affections and process for its preparation |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8148563B2 (en) | 2006-02-03 | 2012-04-03 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US8505730B2 (en) | 2008-01-04 | 2013-08-13 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2153653A (en) | Irradiated dusting powder | |
| NL7601628A (en) | BIOLOGICALLY ACCEPTABLE CERAMIC GLASS AND USE OF THE GLASS FOR MANUFACTURE OF BONDER PROTESES AS WELL AS PROTESIS OBTAINED. | |
| ES2017471B3 (en) | DRESSING FOR WOUND TREATMENT AND PREPARATION PROCEDURE. | |
| ATE127691T1 (en) | USE OF VITAMIN D ANALOGUE TO TREAT ACNE. | |
| IT1040521B (en) | COMPOSITION OF X-RAY ORACA METALCRYLATE PARTICULARLY SUITABLE FOR THE CONSTRUCTION OF PROSTHESES TO BE INCORPORATED IN HUMAN OR ANIMAL ANATOMICAL TISSUES AND RELATED PRODUCTION PROCESS | |
| KR880003620A (en) | Therapeutic Composition and Method | |
| DE68921979D1 (en) | ANTIBODIES FOR ANTILYMPHOCYTIC ANTIBODY THERAPY. | |
| Wollina et al. | Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma | |
| Arnesen | Fracture of the os calcis and its treatment. II. A contribution to the discussion on the treatment of calcaneus fracture based on an analysis of a ten-year material treated by closed reduction and traction, from Sentralsykehuset i Trondheim | |
| DE3775278D1 (en) | TOPICAL METHOTREXATE PREPARATION FOR TREATING HYPERPROLIFERATIVE EPITHELIC DISEASES. | |
| AT154587B (en) | Process for the production of a scattering powder. | |
| JPS5587713A (en) | Weakly acidic nursery powder | |
| GB402033A (en) | Improvements in and relating to therapeutic agents | |
| Sun et al. | Effect of selenium in recovery of immunity damaged by H 2 O 2 and 60 Co radiation | |
| SU88972A1 (en) | A method for the treatment of some benign neoplasms of integumentary tissues | |
| JPS57144225A (en) | Antigenetic preparation for treating nonspecific allergic diseases and its preparation | |
| Azuma | Effects of Ca-and K-Ions and Ultra-Violet rays upon involuntary muscles | |
| Alfadil Mohamed et al. | Vitamin D as a Possible Factor that Reduces COVID-19 Complications | |
| Wyman et al. | The value of different types of glass for transmitting ultraviolet light | |
| ES2033501T3 (en) | PROCEDURE FOR THE PREPARATION OF LOWER SODIUM POLYSULPHIDE FROM SUPERIOR SODIUM POLISHES AND SODIUM. | |
| Kagawa | Examination of Results of Treatments to Foot Deformities (II) Foot Modifications by Scarred-arrested Contract | |
| SU42671A1 (en) | The method of preparation of cosmetics | |
| Toba et al. | The Results of Treatment of Supracondylar Fractures of the Humerus in Children | |
| Yasuda et al. | Examination of Prognosis of Comminuted Fractures on Lower Extremities | |
| Resemblance | " Hydrogen Sulfide Poisoning: Report of 2 Cases, Outcome |